Has Mary Dek received payments from drug or device companies?

Yes. Drug and device makers reported $2,392 in general payments to Mary Dek across 137 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Dek did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Dek come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Dek

Pediatrics · Elkhorn, NENPI 1124187984

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 24.9% of the total. Reporting peaked in 2021 at $534 and has fallen 52.2% since, to $255 in 2025. Among pediatrics clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,392in general payments, 2019–2025

Across 137 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$597
Pfizer$283
Sanofi Pasteur Inc.$121
Neos Therapeutics, LP$119
Kaleo, Inc.$115
Takeda Pharmaceuticals U.S.A., Inc.$104
plus $1K from 23 others

What the payments were for

Food & beverage$2,392100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	24	$597
Pfizer	23	$283
Sanofi Pasteur Inc.	6	$121
Neos Therapeutics, LP	8	$119
Kaleo, Inc.	8	$115
Takeda Pharmaceuticals U.S.A., Inc.	8	$104
Ironshore Pharmaceuticals Inc.	6	$91
Merck	6	$87
Tris Pharma Inc	5	$86
AstraZeneca	4	$82
Sanofi-aventis U.S. LLC	4	$78
Alk-abello, Inc	5	$76
Novartis	4	$68
Genentech USA, Inc.	3	$59
Seqirus USA Inc	2	$53
Hologic Sales And Service, LLC	2	$50
Corium, LLC	2	$46
Sobi, Inc	2	$43
Adlon Therapeutics L.p.	2	$33
Shire North American Group Inc	2	$29
GSK	2	$24
Vertical Pharmaceuticals, LLC	2	$24
Teva Pharmaceuticals USA, Inc.	1	$23
Kyowa Kirin, Inc.	1	$21
Acadia Pharmaceuticals Inc	1	$17
Sarepta Therapeutics, Inc.	1	$17
Biomarin Pharmaceutical Inc.	1	$17
ARS Pharmaceuticals Operations, Inc.	1	$16
Collegium Pharmaceutical, Inc.	1	$13

How this compares

$2,392 in reported general payments places this provider in the 90th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska →

Other pediatrics in Elkhorn

Amanda VotrubaElkhorn$3K
Emilio ArispeElkhorn$3K
Sarah BroadheadElkhorn$2K
Kurt DaveyElkhorn$2K
Thomas ByrneElkhorn$1K
Patrick SteinauerElkhorn$1K
Sheila IsaacsonElkhorn$961
Sachit PatelOmaha$91K
Rachel AndersonOmaha$76K
Amy LacroixOmaha$40K

See the full list for Nebraska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →